|
September is Ovarian and Prostate Cancer Awareness Month. According to the American Cancer Society, ovarian cancer ranks fifth in cancer deaths among women and accounts for more deaths than any other cancer of the female reproductive system.
Among only cancers, prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. More than 2 million men in the United States count themselves as prostate cancer survivors.
Screening is a safe, effective way to diagnose or minimize the risk for cancers.
Whether you’re worried about developing ovarian or prostate cancer, making decisions about your treatment, or trying to stay well after treatment, Crittenton Hospital Medical Center is one of the top three cancer programs in Oakland County.
Advancements of imaging diagnostic procedures for breast and ovarian cancers. Dramatic technological changes in the last 15 years, including digital mammography and breast ultrasound, eliminate guesswork from exams. For patients with family history of breast and ovarian cancer, breast MRIs every year or every other year, in addition to mammograms, are crucial.
Early detection is key in the successful treatment of prostate cancer. The three signs of detection are the PSA blood test, physical examinations, and prostate ultrasound. Patients may delay diagnosis and treatment because they're afraid to come into urologists, but because many of the treatments are office- and medically-based, they can go home on the same day.
Have you been screened recently?
Crittenton Hospital Medical Center (CHMC) provides comprehensive, community-based cancer care to the greater Rochester community. For more information on our cancer services, please call (248) 844-4000. Or visit: http://www.crittenton.com/cancer
|